Protocols at a Glance
PATIENT QUESTIONAIRRE
If you would like to be screened for a study, you can download the data-base questionnaire, complete and mail.
Debbie Slamowitz, RN
ACTG Office
Hoover Pavillion
211 Quarry Rd, N229
Palo Alto, CA 94304-5714
Questionairre.pdf
| Protocols | ACTG Protocols | Status |
|---|---|---|
| ACTG 5240 | Phase 2 study of HPV vaccine in HIV-1 Infected Females | Now Recruiting |
| ACTG 5241 | The Optimized Treatment that includes or Omits NRTIs (OPTIONS) Trial |
Now Recruiting |
| ACTG 5247 | Evaluation of therapy with ZOSTAVAX® for HIV-1-Infected Adults on ART with Conserved Immune Function | Recruitment on hold until Dec 12/09. Call for more information |
| ACTG 5257 | A phase III, prospective, randomized, open-label trial comparing three NNRTI-sparing antiretroviral (ARV) regimens | Now Recruiting |
NON ACTG Protocols Open at Stanford |
||
| POEM Study | An international, multicenter, prospective observational comparative study to monitor the safety of long term use of maraviroc in a larger and more diverse patient population |
Now Recruiting |
| Victor E4 | Vicriviroc in Combination Treatment with an Optimized ART Regimen in HIV-Infected Treatment-Experienced Subjects | Now recruiting |